Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine and Famotidine in Long COVID Feasibility Study
NCT05946551Phase 3Terminated
- Sponsor
- Emory University
- Start
- Mar 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cetirizine, famotidine in post-COVID-19 condition (PCC), sponsored by Emory University. Started Mar 2024; status: terminated.
02
Drugs
cetirizinefamotidine
03
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT05946551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05946551.